EDGAR Filing Documents for 0001213900-22-040965

Form 8-K - Current report:

SEC Accession No. 0001213900-22-040965

Filing Date

2022-07-22

Accepted

2022-07-22 15:44:36

Documents

Period of Report

2022-07-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea163189-8k_immune.htm iXBRL	8-K	35365
2	CONVERTIBLE PROMISSORY NOTE IN THE PRINCIPAL AMOUNT OF $100,000, DATED JULY 19,	ea163189ex4-1_immune.htm	EX-4.1	32253
3	CONVERTIBLE PROMISSORY NOTE IN THE PRINCIPAL AMOUNT OF $100,000, DATED JULY 19,	ea163189ex4-2_immune.htm	EX-4.2	32187
4	CONVERTIBLE PROMISSORY NOTE IN THE PRINCIPAL AMOUNT OF $200,000, DATED JULY 19,	ea163189ex4-3_immune.htm	EX-4.3	32706
5	SEPARATION AND RELEASE AGREEMENT, DATED JULY 19, 2022, BETWEEN KEVIN PHELPS AND	ea163189ex10-1_immune.htm	EX-10.1	248295
6	PRESS RELEASE DATED JULY 22, 2022	ea163189ex99-1_immune.htm	EX-99.1	7628
10	GRAPHIC	ex10-1_001.jpg	GRAPHIC	3581
	Complete submission text file	0001213900-22-040965.txt		653206

Data Files

Seq	Description	Document	Type	Size
7	XBRL SCHEMA FILE	imun-20220718.xsd	EX-101.SCH	2989
8	XBRL LABEL FILE	imun-20220718_lab.xml	EX-101.LAB	34240
9	XBRL PRESENTATION FILE	imun-20220718_pre.xml	EX-101.PRE	22379
12	EXTRACTED XBRL INSTANCE DOCUMENT	ea163189-8k_immune_htm.xml	XML	3287

Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792

Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802

Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)